Cargando...
Combined model-based and patient-specific dosimetry for (18)F-DCFPyL, a PSMA-targeted PET agent
PURPOSE: Prostate-specific membrane antigen (PSMA), a type-II integral membrane protein highly expressed in prostate cancer, has been extensively used as a target for imaging and therapy. Among the available PET radiotracers, the low molecular weight agents that bind to PSMA are proving particularly...
Guardado en:
| Publicado en: | Eur J Nucl Med Mol Imaging |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5918228/ https://ncbi.nlm.nih.gov/pubmed/29460025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-3939-x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|